It's official. I have been randomized into my clinical trial and will receive the standard treatment of FCR. Fludarabine (F) and cyclophosphamide (C) are chemotherapy drugs that prevent cancer cells from dividing and growing, and can eventually cause the cancer cells to shrink and die. Rituximab (R) is a new type of drug, called a monoclonal antibody, which targets cancer cells more precisely than chemotherapy drugs. What's "nice" is that it's three days of treatment and 25 days off. Then five more of the same. T-minus 5 days and the games begin.
No comments:
Post a Comment